Latest stories on EOLS
Evolus to Participate in Upcoming Investor Conferences in New York and London
StockTitan52 · neutralproduct/pr
Evolus to Report Third Quarter Financial Results on November 4, 2026
StockTitan50 · neutralgeneral
Evolus enters option agreement with privately held company
The Fly52 · neutralgeneral
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
StockTitan58 · neutralproduct/pr
FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
Stocktwits News38 · neutralgeneral
Evolus drops as FDA says Jeuveau Instagram post is misleading
Seeking Alpha34 · bearishgeneral
Evolus falls 5% to $7.12 after FDA send letter over marketing
The Fly34 · bearishgeneral
FDA sends letter to Evolus over ‘misleading’ Jeuveau ad
The Fly38 · neutralgeneral
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
StockTitan56 · neutralproduct/pr
Evolus weakness a buying opportunity, says Mizuho
The Fly58 · neutralanalyst
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
Yahoo Finance67 · bullishearnings
Evolus: The Injectable Platform Is Becoming The Real Moat
Seeking Alpha63 · neutralproduct/pr
Evolus, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Evolus Lifts 2026 Guidance After Third Consecutive Quarter of Positive Adjusted EBITDA
August 6, 2026
MarketChameleon73 · bullishearnings
Evolus targets $450M-$500M revenue and 13%-15% adjusted EBITDA margin in 2028 while raising 2026 revenue outlook to $330M-$337M
Seeking Alpha71 · bullishearnings
Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Evolus Q2 Earnings Call Highlights
Yahoo Top68 · bullishearnings
Evolus Inc. Earnings Call Signals Confident Growth
TipRanks63 · neutralearnings
Evolus GAAP EPS of -$0.12 beats by $0.01, revenue of $84.1M beats by $2.56M
Seeking Alpha63 · neutralearnings
Evolus, Inc. (EOLS) files 8-K
SEC 8-K50 · neutralgeneral
Evolus, Inc. (EOLS) files 8-K
SEC 8-K50 · neutralgeneral
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
StockTitan56 · neutralproduct/pr
Evolus to Report Second Quarter Financial Results on August 5, 2026
StockTitan50 · neutralearnings
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News
StockTitan50 · neutralgeneral